Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Alan Caley who wrote (1160)	2/4/2001 11:49:47 AM
From: Ian@SI	Respond to of 1321

Hi Alan, I forgot to put the smile emoticon after the comment about "regular user" and 1 post since 1996. Sorry about that. But you've now doubled your posts in only one day. :-) Don't get so carried away. <vbg> ARMD (wet form) normally leads to blindness in about 4 years. Next year, QLT will be the only company which with evidence from its PhIII trials showing that it has arrested / cured the condition. In addition, label expansion is, IMO, likely to double the revenue estimates for this company. And I believe that people will continue to go blind, recession or not. Its revenues are more secure during a recession than those of most other companies. Take care, Ian.